JD-5037
|
|
|
- CAS号:
- 1392116-14-1
- 英文名:
- JD-5037
- 英文别名:
- CS-2558;JD-5037;JD 5037;JD-5037;Cannabinoid Receptor,inhibit,JD5037,JD-5037,Inhibitor;(S)-2-((((S)-3-(4-Chlorophenyl)-4-phenyl-4,5-dihydro-1H-pyrazol-1-yl)(4-chlorophenylsulfonamido)methylene)amino)-3-methylbutanamide;(S)-2-((Z)-(((S)-3-(4-chlorophenyl)-4-phenyl-4,5-dihydro-1H-pyrazol-1-yl)(4-chlorophenylsulfonamido)methylene)amino)-3-methylbutanamide;Butanamide, 2-[[[(4S)-3-(4-chlorophenyl)-4,5-dihydro-4-phenyl-1H-pyrazol-1-yl][[(4-chlorophenyl)sulfonyl]amino]methylene]amino]-3-methyl-, (2S)-
- 中文名:
- JD-5037
- 中文别名:
- 化合物JD5037;(S)-2-((((S)-3-(4-氯苯基)-4-苯基-4,5-二氢-1H-吡唑-1-基)(4-氯苯基磺胺基)亚甲基)氨基)-3-甲基丁酰胺
- CBNumber:
- CB23167616
- 分子式:
- C27H27Cl2N5O3S
- 分子量:
- 572.51
- MOL File:
- 1392116-14-1.mol
|
|
|
JD-5037化学性质
-
沸点:
-
721.6±70.0 °C(Predicted)
-
|
-
密度:
-
1.40±0.1 g/cm3(Predicted)
-
|
-
储存条件:
-
Store at -20°C
-
|
-
溶解度:
-
≥143.2 mg/mL in DMSO; insoluble in EtOH; insoluble in H2O
-
|
-
酸度系数(pKa):
-
10.63±0.60(Predicted)
-
|
JD-5037性质、用途与生产工艺
JD-5037是cannabinoid-1 receptor阻滞剂，对CB1受体的IC50值为2 nM，而对CB2受体的IC50值大于1000 nM。
| Target | Value |
CB1 receptor
()
|
2 nM
|
JD5037 (3 mg/kg/d, i.p.) induces equal reductions in body weight, attenuates the HFD-induced hyperglycemia, and reduces the HFD-induced hepatic injury and steatosis in obese Magel2-null mice. JD5037 (3 mg/kg/day, p.o.) significantly reduces the size of tumors and abrogates the tumor in DEN-treated mice. JD5037 attenuates the AEA levels in HCC samples from mice.
JD-5037
上下游产品信息
上游原料
下游产品
| 更新日期 | 产品编号 | 产品名称 | CAS编号 | 包装 | 价格 |
|---|
| 2024/04/30 | HY-18697 | JD-5037 | | 1 mg | 390元 |
| 2024/04/30 | HY-18697 | JD-5037
JD-5037 | 1392116-14-1 | 5mg | 860元 |
1392116-14-1, JD-5037 相关搜索:
- 合成有机化合物配体
- C27H27Cl2N5O3S
- (S)-2-((((S)-3-(4-氯苯基)-4-苯基-4,5-二氢-1H-吡唑-1-基)(4-氯苯基磺胺基)亚甲基)氨基)-3-甲基丁酰胺
- 化合物JD5037
- 1392116-14-1
- (S)-2-((((S)-3-(4-Chlorophenyl)-4-phenyl-4,5-dihydro-1H-pyrazol-1-yl)(4-chlorophenylsulfonamido)methylene)amino)-3-methylbutanamide
- Cannabinoid Receptor,inhibit,JD5037,JD-5037,Inhibitor
- Butanamide, 2-[[[(4S)-3-(4-chlorophenyl)-4,5-dihydro-4-phenyl-1H-pyrazol-1-yl][[(4-chlorophenyl)sulfonyl]amino]methylene]amino]-3-methyl-, (2S)-
- JD 5037;JD-5037
- CS-2558
- (S)-2-((Z)-(((S)-3-(4-chlorophenyl)-4-phenyl-4,5-dihydro-1H-pyrazol-1-yl)(4-chlorophenylsulfonamido)methylene)amino)-3-methylbutanamide
- JD-5037